Page last updated: 2024-12-06
nopinone
Description
Nopinone is a bicyclic ketone derived from α-pinene. It is a chiral molecule, and its enantiomers exhibit different biological activities. Nopinone is known for its antimicrobial, insecticidal, and anti-inflammatory properties. It has been studied for its potential applications in pharmaceutical and agricultural industries. Nopinone can be synthesized from α-pinene through a series of reactions involving oxidation and rearrangement. The unique structure and biological activity of nopinone make it an interesting target for research and development.'
nopinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 32735 |
CHEBI ID | 181453 |
SCHEMBL ID | 720591 |
MeSH ID | M0452883 |
Synonyms (31)
Synonym |
LS-13665 |
CHEBI:181453 |
.beta.-pinone |
24903-95-5 |
nopinon |
nopinone |
nsc135004 |
nsc-135004 |
bicyclo[3.1.1]heptan-2-one,6-dimethyl- |
2-norpinanone,6-dimethyl- |
6,6-dimethylbicyclo[3.1.1]heptan-2-one |
(1r)-(+)-norinone |
bicyclo[3.1.1]heptan-2-one, 6,6-dimethyl- |
nsc250997 |
(1r)-6,6-dimethyldicyclo[3.1.1]heptan-2-one |
AKOS004907716 |
bicyclo(3.1.1)heptan-2-one, 6,6-dimethyl- |
2-norpinanone, 6,6-dimethyl- |
nsc 135004 |
6,6-dimethylbicyclo(3.1.1)heptan-2-one |
einecs 246-520-3 |
beta-pinone |
FT-0639485 |
SCHEMBL720591 |
6,6-dimethyl-bicyclo[3.1.1]heptan-2-one |
CS-0101275 |
DTXSID20865173 |
SY211609 |
A936770 |
SB45077 |
EN300-182727 |
Drug Classes (1)
Class | Description |
monoterpenoid | Any terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 29.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 29.72 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 34.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |